API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 2 sources · 25 days · First seen · Last updated

Rare disease and healthcare management in Italy

Overview

In late September 2026, Italy officially recognized developmental and epileptic encephalopathies (Dee) as rare diseases by updating the Essential Levels of Assistance (Lea). This regulatory change, which introduced the new exemption group code RFG102, consolidated several conditions—including Dravet, Lennox-Gastaut, West, and Landau-Kleffner syndromes—to address previous gaps in national coding and facilitate more equitable healthcare access.

Subsequent reports highlighted broader challenges in managing rare neurological conditions and mental health within the Italian healthcare and educational systems. These accounts emphasized the necessity of multidisciplinary care for autoimmune diseases like Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and underscored the need for better coordination between schools, families, and mental health professionals to support students in crisis.

Entities

Italy · Lice · Doriana Medici · Sveva · Fidenza Hospital

Timeline

  1. [HEALTH] 2 sources
    Italy: Challenges in managing rare diseases and youth mental health

    Reports from Italy highlight the difficulties of managing rare autoimmune diseases like CIDP and the urgent need for better coordination between schools and mental health services to support youth in crisis.

  2. [HEALTH] 6 sources
    Italy recognizes developmental and epileptic encephalopathies as rare diseases

    Italy has officially added developmental and epileptic encephalopathies to its list of rare diseases, introducing the RFG102 exemption code to ensure equitable healthcare access for patients.

Sources

cidp.it · giornaleadige.it